Cargando…
Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
Autores principales: | Vincent, L, Ceballos, P, Plassot, C, Méniane, J C, Quittet, P, Navarro, R, Cyteval, C, Szablewski, V, Lu, Z Y, Kanouni, T, Moreaux, J, Cartron, G, Klein, B, Fegueux, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558584/ https://www.ncbi.nlm.nih.gov/pubmed/26295611 http://dx.doi.org/10.1038/bcj.2015.48 |
Ejemplares similares
-
Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
por: Caraux, Anouk, et al.
Publicado: (2012) -
Extramedullary Relapse in a CML Patient after Allogeneic Stem Cell Transplantation
por: Yilmaz, Asu Fergun, et al.
Publicado: (2017) -
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
por: Lamure, Sylvain, et al.
Publicado: (2020) -
Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma
por: Tudesq, Jean-Jacques, et al.
Publicado: (2017) -
Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs
por: Köse, Murat, et al.
Publicado: (2015)